Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)
0.1864
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.686B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 89.06% |
| Valuation | |
| PE Ratio | 69.06 |
| PE Ratio (Forward) | |
| PS Ratio | 4.666 |
| Price to Book Value | 15.25 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0014 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 79.50% |
Profile
| Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China. |
| URL | http://www.sihuanpharm.com |
| Investor Relations URL | N/A |
| HQ State/Province | Beijing |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Aug. 28, 2026 (est.) |
| Last Earnings Release | Mar. 31, 2026 |
| Next Ex-Dividend Date | Jul. 02, 2026 |
| Last Ex-Dividend Date | Sep. 30, 2025 |
Profile
| Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China. |
| URL | http://www.sihuanpharm.com |
| Investor Relations URL | N/A |
| HQ State/Province | Beijing |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Aug. 28, 2026 (est.) |
| Last Earnings Release | Mar. 31, 2026 |
| Next Ex-Dividend Date | Jul. 02, 2026 |
| Last Ex-Dividend Date | Sep. 30, 2025 |